|
2024 Financial Outlook |
|||
|
Dollars in millions, unless noted |
1Q’24E |
Full Year 2024E |
|
|
Net sales |
~$2,800 |
$11,900 – $12,300 |
|
|
Operating EBITDA(2) |
~$610 |
$2,800 – $3,000 |
|
|
Adjusted EPS(2) |
$0.63 – $0.65 |
$3.25 – $3.65 |
|
electroCore Expands Intellectual Property Portfolio; The Two Patents Were Issued On December 26, 2023, And Relate To ElectroCore’s Non-Invasive Vagus Nerve Stimulation Technology
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO).
